Year archive

BCAL DIAGNOSTICS LIMITED — 2022 filings

All 31 regulatory filings released by BCAL DIAGNOSTICS LIMITED (BDX) in 2022, sourced directly from the official regulator.

31 Filings

2022 Period

2022 filings (31)

Filing	Released	Lang
Results of Meeting 2 pages 181.6KB Regulatory Filings	2022-11-30	English
BCAL AGM Presentation 22 pages 2.0MB Regulatory Filings	2022-11-28	English
Results of Meeting 2 pages 180.7KB Regulatory Filings	2022-11-28	English
Shareholder Newsletter 4 pages 2.8MB Regulatory Filings	2022-11-15	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 140.6KB Regulatory Filings	2022-10-30	English
Notice of Annual General Meeting/Proxy Form 19 pages 746.1KB Regulatory Filings	2022-10-27	English
Letter to Shareholders on Annual General Meeting Notice 1 Regulatory Filings	2022-10-27	English
Establishment of Development & Clinical Service Laboratory 2 pages 49.9KB Regulatory Filings	2022-10-24	English
Annual Report to shareholders 48 pages 1.3MB Regulatory Filings	2022-09-28	English
Appendix 4G and Corporate Governance Statement 25 pages 282.0KB Regulatory Filings	2022-09-28	English
Preliminary Final Report 26 pages 391.8KB Regulatory Filings	2022-08-29	English
Application for quotation of securities - BDX 6 pages 27.7KB Regulatory Filings	2022-08-28	English
Proposed issue of securities - BDX 5 pages 27.5KB Regulatory Filings	2022-08-24	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 115.5KB Regulatory Filings	2022-07-27	English
Change of Director's Interest Notice 3 pages 81.9KB Regulatory Filings	2022-07-03	English
BCAL Enters US Product Development Agreement with Precion 2 pages 59.2KB Regulatory Filings	2022-06-27	English
Change in substantial holding 2 pages 263.8KB Regulatory Filings	2022-06-26	English
BCAL Presentation Accepted for 2022 ASCO Annual Meeting 1 Regulatory Filings	2022-05-31	English
Application for quotation of securities - BDX 6 pages 27.8KB Regulatory Filings	2022-05-02	English
BCAL to Present at NWR Virtual Investor Conference 1 Regulatory Filings	2022-05-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 195.5KB Regulatory Filings	2022-04-27	English
Shareholder Newsletter 6 pages 336.4KB Regulatory Filings	2022-03-23	English
Change of Director's Interest Notice 2 pages 78.3KB Regulatory Filings	2022-03-01	English
Appendix 4D & Interim Report 18 pages 824.2KB Regulatory Filings	2022-02-17	English
Shares to be released from escrow 1 page 49.6KB Regulatory Filings	2022-02-13	English
7 February Announcement - Additional Information 3 pages 112.0KB Regulatory Filings	2022-02-07	English
Recent Analysis Significantly Improves Commercial Prospects 2 pages 54.3KB Regulatory Filings	2022-02-06	English
Appendix 4C Revised 6 pages 96.5KB Regulatory Filings	2022-02-03	English
Becoming a substantial holder 4 pages 203.1KB Regulatory Filings	2022-01-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 117.5KB Regulatory Filings	2022-01-26	English
Dr John Hurrell Appointed Chief Executive Officer 2 pages 56.2KB Regulatory Filings	2022-01-10	English